According to the agreement, SciSparc’s pharmaceuticals assets and equity stake in SciSparc Nutraceuticals Inc. are valued at approximately US$11.6 million TEL AVIV, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that on October 9, 2025, the Company entered into a definitive asset and s ...

The framework agreement targets multi-gigawatt solar module frame supply over several years valued at over $75 millionFREMONT, Calif. and AUSTIN, Texas, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nextracker (NASDAQ: NXT), a leading solar technology platform provider, and T1 Energy Inc. (NYSE: TE), an advanced manufacturer of solar modules, today announced a strategic framework agreement to use Nextracker’s patented steel module frame technology for T1 Energy’s new 5-GW G1_Dallas solar manufacturing facility. The agr ...

Operational improvements across key metricsMONTREAL, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce record quarterly production, recoveries, and throughput at its Zgounder Silver Mine in the Kingdom of Morocco for the three-month period ended September 30, 2025. Q3-2025 Operational Summary Record silver production of 1.35 million (“M”) ounces (“oz”), a 29% increase over Q2 2025, driven by higher throughput and improved gr ...

SINGAPORE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global AI-powered audio company, today announced that its Founder, Chief Executive Officer and Chairman, Jinnan (Marco) Lai, recently purchased the Company’s shares in the open market. “The accelerating development and expanding global applications of Voice AI are unlocking Sound Group’s even greater growth potential,” said Mr. Lai. “My personal investment reflects my strong confidence in the Com ...

Core Viewpoint - Guardian Capital Group Limited has received recommendations from leading independent proxy advisory firms ISS and Glass Lewis to vote in favor of a special resolution for a plan of arrangement that offers shareholders C$68.00 per share, representing significant premiums over previous trading prices [1][2][3] Summary by Sections Arrangement Details - The Arrangement offers shareholders a cash consideration of C$68.00 per share, which is a premium of 66% over the last closing price of Class A Shares and 48% over Common Shares as of August 27, 2025 [1] - The premium also reflects a 65% and 54% increase over the 30-day volume-weighted average trading price for Class A and Common Shares, respectively [1] Recommendations - ISS stated that the offer represents a meaningful premium to the unaffected price and that the valuation appears reasonable, highlighting the immediate cash exit for non-rolling shareholders [2] - Glass Lewis concluded that the proposed transaction is favorable for public shareholders, considering the company's standalone prospects and the negotiation process [2] Board of Directors' Position - The Board of Directors, after receiving legal and financial advice, unanimously recommends that shareholders vote for the Arrangement, deeming it in the best interests of the company and fair to shareholders [3] Meeting Information - A special meeting for shareholders to vote on the Arrangement is scheduled for October 23, 2025, with a proxy voting deadline of October 21, 2025 [4][5] Voting Process - Shareholders are encouraged to vote online or by telephone due to potential delays in mail delivery caused by a national postal strike [8][9] Rollover Shareholders - Certain shareholders, referred to as Rollover Shareholders, will receive a mix of shares and cash as part of the Arrangement, with a total of 7,667,390 shares being transferred [9][11]

New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinomaTARRYTOWN, N.Y., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its advancing oncology pipeline will be shared in seven abstracts at the European Society for Medical Oncology (ESMO) 2025 Meeting, taking place from October 17-21 in Berlin, Germ ...

VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK), (“EnviroGold,” or the “Company”) is pleased to announce that, in response to strong investor demand, it has increased the size of its previously announced non-brokered private placement (the “Offering”). The Company now intends to raise gross proceeds of up to $7,000,000 through the issuance of units at a price of $0.09 per unit. On October 1, 2025, the Company closed the first tra ...

Core Insights - Energous Corporation is experiencing significant commercial and financial momentum due to increasing customer adoption and demand for its wireless power network solutions [1][6] Financial Performance - For Q3 2025, Energous expects to report revenue of approximately $1.3 million, a more than sixfold increase year-over-year and a 31% increase from the previous quarter [2] - This revenue marks the highest quarterly figure since 2015, contributing to a year-to-date revenue of approximately $2.6 million, representing a 237% increase over full-year 2024 revenue [3] - The company anticipates an operational loss between $2.1 million and $2.3 million for Q3 2025, the lowest since 2014, showing improvement from a $2.8 million loss in Q2 2025 [4] Order Backlog and Customer Engagement - Energous has a confirmed order backlog of approximately $4.2 million as of October 10, 2025, driven by major enterprise deployments, including commitments from a Fortune 10 company [6][10] - The Fortune 10 customer has expanded its deployment scope to include nationwide stores, focusing on supply chain modernization [7] Technological Advancements - Energous' end-to-end wireless power solution supports the unique power requirements of ambient IoT, featuring battery-free E-Sense sensors and RF-based energy transmitters [8] - The architecture allows for continuous sensing at scale without the costs and complexities associated with battery maintenance [9] Future Outlook - The company is finalizing plans to launch a new series of wireless power products to enhance its network capabilities and support broader adoption across key verticals [9] - Energous is engaged in proof-of-concept projects with global leaders in various industries, validating its market readiness and scalability [7][10]

DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Rela ...

Core Viewpoint - ASP Isotopes Inc. has announced a public offering of 17,167,380 shares of its common stock, aiming to raise approximately $210.3 million before expenses, with the offering expected to close on October 16, 2025 [1][4]. Group 1: Offering Details - The company has granted underwriters a 30-day option to purchase approximately $31.5 million of additional shares at the offering price [2]. - The last sale price of the shares on October 14, 2025, was reported at $14.05 per share [3]. - The offering is made under a shelf registration statement filed with the SEC on October 14, 2025, which became effective upon filing [5]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for general corporate purposes, including working capital, operating expenses, and capital expenditures [4]. Group 3: Company Overview - ASP Isotopes Inc. is focused on developing technology and processes for isotope production, particularly for healthcare and technology industries, utilizing proprietary Aerodynamic Separation Process technology [7]. - The company plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [7]. - There is a growing demand for various isotopes, including Silicon-28 for quantum computing and Molybdenum isotopes for healthcare applications, indicating a robust market potential for the company's offerings [8].